🥸Kidney stones that require metabolic evaluation of patient academic.oup.com/pmj/article/...

🧬Complement Pathways and Regulators in Kidney Ds doi.org/10.1093/ndt/... @hjanders.bsky.social

😩Gout Management in CKD www.ajkd.org/article/S027... @ajkd.bsky.social

Claim your travel grant for #ISNCON25 ‼️ Submit your abstract here: isn-india.org/isn_registra... @jasminenephro.bsky.social @sayalibthakare.bsky.social @thisis-drgsp2.bsky.social @arvindcanchi.bsky.social

🫘Non invasive biomarkers of Rejection pubmed.ncbi.nlm.nih.gov/39419272/ @ajkd.bsky.social

🫘Renal Amyloidosis academic.oup.com/ndt/article-... @hjanders.bsky.social

💊🫘Drugs to prevent CKD Progression doi.org/10.1093/ndt/... @hjanders.bsky.social

🌟Beyond Testing—IgAN Trials Unveiled!-Must Read🌟 From #Sparsentan to #Iptacopan, innovative non-immunomodulatory & immunomodulatory therapies are transforming IgAN care!🎯 🔬 Excellent Trial insights by @Melgreux 📖 via @KidneyKolumns Jan25 #Nephrology #IgAN #ClinicalTrials

🫘🎯Light chain Amyloidosis 😬Kidneys 🫘 and heart most commonly involved 🎯Mostly nephrotic range proteinuria @nejm.org www.nejm.org/doi/full/10....

When should the nephrologist think about genetics in patients with glomerular diseases? doi.org/10.1093/ckj/...

👍New Lupus Nephritis guidelines #ACR2024 🤘Major change-Triple therapy for induction ✅

🦠🫘Approach to BKV in kidney transplant recipients doi.org/10.1093/ndt/... @hjanders.bsky.social

🤔🤔Ever heard of DMANDs-Disease modifying anti nephropathic drugs doi.org/10.1093/ndt/... @hjanders.bsky.social #Nephsky #Nephpearls

The low statin use in CKD is a scandal It’s a 1A in the guideline but hardly noticed by most - so made it my draft pick www.nephjc.com/freelyfilter... on @freelyfiltered.bsky.social #Statins4All #NephSky

🫘Hyperuricemia management in CKD ❌DO NOT use urate lowering drugs in CKD with asymptomatic Hyperuricemia @nephjc.bsky.social @kdigo.org #NephPearls #NephSky

🫘Approach to high flow hemodialysis vascular access #NephSky #Nephpearls doi.org/10.23876/j.k...

KDIGO: Every CKD patient should be on a statin KDIGO ADPKD Guidelines

🤗🫘Great insights, inspiring discussions and amazing connections at ISN WCN @theisn.org @isn-india.bsky.social #ISNWCN

🫘When to do kidney biopsy in diabetes academic.oup.com/ckj/advance-... @ckj-era.bsky.social

📝Medical therapy in CKD-RAASi, SGLT2i , GLP1RA and Non steroidal MRA doi.org/10.1093/ndt/... @hjanders.bsky.social

😎ADPKD bedside must know questions/pearls @isn-india.bsky.social social media Team has launched the clinical online bedside series 🎯Sharing some pearls from the first bedside @arvindcanchi.bsky.social @isn-india.bsky.social

🫘🧬What’s new in Acute kidney injury Proteomics Artificial intelligence And more doi.org/10.1093/ckj/...

🦠Viral Nephropathies www.ajkd.org/article/S027... @ajkd.bsky.social

Do not miss this exciting Bedside clinics in Nephrology series 😎

🫘Breaking barriers and gender bias in Nephrology Interesting read in CJASN by @kidneydoc101.bsky.social journals.lww.com/cjasn/pages/...

💇‍♀️Brazilian hair straightening and Oxalate Nephropathy 😱 www.kidney-international.org/article/S008...

🫘Rhabdomyolysis AKI management journals.lww.com/cjasn/fullte... CJASN

🫘Proteinuria types UpToDate

🫘🤩Renal tubular acidosis simplified Source UpToDate

🌱Nature’s beauty captured in a moment 📸

👍New Lupus Nephritis guidelines #ACR2024 🤘Major change-Triple therapy for induction ✅

💯Approach to elevated Ferritin Infographic @bmj.com

🫘👍CKD guidelines of evaluation and management ow.ly/Fzkc50U2AtZ @gokdigo.bsky.social

🫘C3 Glomerulopathy Presentation NDT journal doi.org/10.1093/ndt/...

🫁Lung Transplantation www.nejm.org/doi/full/10.... NEJM

👧Pediatric CRRT indications link.springer.com/article/10.1...

🫘Oral antibiotics for UTI @ajkd.bsky.social core curriculum

🫘🧬Complement testing in patients with C3 Glomerulopathy doi.org/10.1093/ndt/... @ndt journal

🫘💊OHA dose modification in CKD @ajkd.bsky.social core curriculum

👍Hypocalcemia Approach

Nephrotic 🆚Nephritic syndrome From Curbsiders